BKCG, BNY Mellon's Concentrated Growth ETF, has quietly put together its best month of the year — up nearly 10% over the past 30 days to close at $37.30 — while the short-selling community has essentially nothing to say about it.
Short positioning is negligible by any measure. Estimated short interest is a fraction of 1% of the float, and lending-pool availability is so deep — running at effectively the maximum measurable level — that there is no borrow pressure whatsoever. The ORTEX short score has barely moved in months, sitting at 26.5, well within the lower third of the 0-100 scale. There is no bear-side story here worth developing.
What is worth noting is the price momentum. BKCG added roughly 1% on the week and 9.5% over the past month, in line with a broad recovery in growth-oriented equity strategies. The ETF's concentrated mandate — by design it holds a small, high-conviction basket of growth names — means it tends to amplify moves in whatever large-cap growth cohort it tracks. A near-10% monthly gain with only 0.16% added yesterday suggests the bulk of that move happened in earlier sessions, and the pace has moderated into the end of the week.
Cost to borrow has been stable around 2.58% for several weeks, essentially unchanged from the prior reading. That rate is unremarkable for a small ETF and reflects routine rather than stress. The lending market is loose, and nothing in the short data points to any shift in that posture.
The dividend history in the data reflects a separate, older BNY Mellon fund structure and is not relevant to this ETF. No earnings events apply, as BKCG is a passively structured product.
With a market cap of approximately $119 million, this remains a small, specialist vehicle. The story this week is straightforward: a concentrated growth ETF that moved with the tape, with no positioning dynamic worth watching beyond whether the growth rally that drove May's opening gains has further to run.
See the live data behind this article on ORTEX.
Open BKCG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
